炎症性肠病免疫发病机制的研究进展

被引：42

作者：

张金玲 ^{[1
,2
]}

杜光 ^{[1
]}

李娟 ^{[1
]}

机构：

[1] 华中科技大学同济医学院附属同济医院药学部

[2] 湖北科技学院药学院

来源：

胃肠病学和肝病学杂志 | 2019年 / 28卷 / 09期

关键词：

炎症性肠病; 免疫机制; 治疗;

D O I：

暂无

中图分类号：

R574 [肠疾病];

学科分类号：

100201 [内科学];

摘要：

炎症性肠病(inflammatory bowel disease,IBD)是一种特发性、慢性和复发性肠道炎症性疾病,其发病机制受到环境、遗传、感染和免疫因素的影响,近年来随着对IBD免疫机制和药物治疗的不断探索,人们对IBD发病机制的认识越来越深入,现从细胞因子参与IBD的发病机制及药物治疗两方面作一概述。

引用

页码：1051 / 1055

页数：5

共 10 条

[1]

Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease [J].

Panes, Julian ;

Garcia-Olmo, Damian ;

Van Assche, Gert ;

Colombel, Jean Frederic ;

Reinisch, Walter ;

Baumgart, Daniel C. ;

Dignass, Axel ;

Nachury, Maria ;

Ferrante, Marc ;

Kazemi-Shirazi, Lili ;

Grimaud, Jean C. ;

de la Portilla, Fernando ;

Goldin, Eran ;

Paule Richard, Marie ;

Carmen Diez, Mary ;

Tagarro, Ignacio ;

Leselbaum, Anne ;

Danese, Silvio .

GASTROENTEROLOGY, 2018, 154 (05) :1334-+

[2]

Anti-NKG2D monoclonal antibody (NNC0142-0002) in active Crohn's disease: a randomised controlled trial [J].

Allez, Matthieu ;

Skolnick, Brett E. ;

Wisniewska-Jarosinska, Maria ;

Petryka, Robert ;

Overgaard, Rune Viig .

GUT, 2017, 66 (11) :1918-1925

[3]

NKG2D ligand expression in Crohn's disease and NKG2D-dependent stimulation of CD8+ T cell migration [J].

Vadstrup, Kasper ;

Galsgaard, Elisabeth Douglas ;

Jensen, Helle ;

Lanier, Lewis L. ;

Ryan, James C. ;

Chen, Shih-Yu ;

Nolan, Garry P. ;

Vester-Andersen, Marianne Kajbaek ;

Pedersen, Julie Steen ;

Gerwien, Jens ;

Jensen, Teis ;

Bendtsen, Flemming .

EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2017, 103 (01) :56-70

[4]

Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines.[J].Peter J. Murray;Judith E. Allen;Subhra K. Biswas;Edward A. Fisher;Derek W. Gilroy;Sergij Goerdt;Siamon Gordon;John A. Hamilton;Lionel B. Ivashkiv;Toby Lawrence;Massimo Locati;Alberto Mantovani;Fernando O. Martinez;Jean-Louis Mege;David M. Mosser;Gioacchino Natoli;Jeroen P. Saeij;Joachim L. Schultze;Kari Ann Shirey;Antonio Sica;Jill Suttles;Irina Udalova;Jo A. van Ginderachter;Stefanie N. Vogel;Thomas A. Wynn.Imm

[5]

Incidence and Phenotype of Inflammatory Bowel Disease Based on Results From the Asia-Pacific Crohn's and Colitis Epidemiology Study [J].

Ng, Siew C. ;

Tang, Whitney ;

Ching, Jessica Y. ;

Wong, May ;

Chow, Chung Mo ;

Hui, A. J. ;

Wong, T. C. ;

Leung, Vincent K. ;

Tsang, Steve W. ;

Yu, Hon Ho ;

Li, Mo Fong ;

Ng, Ka Kei ;

Kamm, Michael A. ;

Studd, Corrie ;

Bell, Sally ;

Leong, Rupert ;

de Silva, H. Janaka ;

Kasturiratne, Anuradhani ;

Mufeena, M. N. F. ;

Ling, Khoon Lin ;

Ooi, Choon Jin ;

Tan, Poh Seng ;

Ong, David ;

Goh, Khean L. ;

Hilmi, Ida ;

Pisespongsa, Pises ;

Manatsathit, Sathaporn ;

Rerknimitr, Rungsun ;

Aniwan, Satimai ;

Wang, Yu Fang ;

Ouyang, Qin ;

Zeng, Zhirong ;

Zhu, Zhenhua ;

Chen, Min Hu ;

Hu, Pin Jin ;

Wu, Kaichun ;

Wang, Xin ;

Simadibrata, Marcellus ;

Abdullah, Murdani ;

Wu, Justin Cy ;

Sung, Joseph J. Y. ;

Chan, Francis K. L. .

GASTROENTEROLOGY, 2013, 145 (01) :158-+

[6]

Treatment of inflammatory bowel disease by chemokine receptor-targeted leukapheresis.[J].Michael Eberhardson;Per Marits;Martina Jones;Petra Jones;Per Karlen;Mats Karlsson;Graham Cotton;Kerry Woznica;Beatrice Maltman;Hans Glise;Ola Winqvist.Clinical Immunology.2013,

[7]

Interleukin-10 and Interleukin-10–Receptor Defects in Inflammatory Bowel Disease.[J].Neil Shah;Jochen Kammermeier;Mamoun Elawad;Erik-Oliver Glocker.Current Allergy and Asthma Reports.2012, 5

[8]

Defective Interleukin-10 Signaling in Human Inflammatory Bowel Disease.[J].Tomohiro Watanabe;Tsutomu Chiba.Gastroenterology.2010, 5

[9]

TNF-α、IL-2以及IL-10在炎症性肠病中的相关性研究 [J].